In last trading session, Xtant Medical Holdings Inc (AMEX:XTNT) saw 0.11 million shares changing hands with its beta currently measuring 0.30. Company’s recent per share price level of $0.47 trading at -$0.03 or -7.45% at ring of the bell on the day assigns it a market valuation of $64.97M. That closing price of XTNT’s stock is at a discount of -176.6% from its 52-week high price of $1.30 and is indicating a premium of 29.79% from its 52-week low price of $0.33. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 83280.0 shares which gives us an average trading volume of 131.37K if we extend that period to 3-months.

For Xtant Medical Holdings Inc (XTNT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.02 in the current quarter.

Xtant Medical Holdings Inc (AMEX:XTNT) trade information

Upright in the red during last session for losing -7.45%, in the last five days XTNT remained trading in the green while hitting it’s week-highest on Friday, 01/03/25 when the stock touched $0.47 price level, adding 20.31% to its value on the day. Xtant Medical Holdings Inc’s shares saw a change of 5.51% in year-to-date performance and have moved 5.51% in past 5-day. Xtant Medical Holdings Inc (AMEX:XTNT) showed a performance of 15.64% in past 30-days. Number of shares sold short was 0.2 million shares which calculate 6.92 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 1.5 to the stock, which implies a rise of 68.67% to its current value. Analysts have been projecting 1.5 as a low price target for the stock while placing it at a high target of 1.5. It follows that stock’s current price would drop -219.15% in reaching the projected high whereas dropping to the targeted low would mean a loss of -219.15% for stock’s current value.

Xtant Medical Holdings Inc (XTNT) estimates and forecasts

This year revenue growth is estimated to rise 28.69% from the last financial year’s standing.

2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 31.8M for the same. And 2 analysts are in estimates of company making revenue of 31.57M in the next quarter. Company posted 28.11M and 27.87M of sales in current and next quarters respectively a year earlier.

In 2025, company’s earnings growth rate is likely to be around -1234.50% while estimates for its earnings growth in next 5 years are of 20.00%.

Xtant Medical Holdings Inc (AMEX:XTNT)’s Major holders

Insiders are in possession of 7.83% of company’s total shares while institution are holding 65.12 percent of that, with stock having share float percentage of 70.66%. Investors also watch the number of corporate investors in a company very closely, which is 65.12% institutions for Xtant Medical Holdings Inc that are currently holding shares of the company. ORBIMED ADVISORS LLC is the top institutional holder at XTNT for having 73.11 million shares of worth $46.06 million. And as of 2024-06-30, it was holding 56.1551 of the company’s outstanding shares.

The second largest institutional holder is ALTIUM CAPITAL MANAGEMENT LP, which was holding about 7.42 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.6953 of outstanding shares, having a total worth of $4.67 million.

On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 1.43 shares of worth $0.67 million or 1.03% of the total outstanding shares. The later fund manager was in possession of 719.48 shares on Sep 30, 2024 , making its stake of worth around $0.34 million in the company or a holder of 0.52% of company’s stock.